iridium has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-García, AR; Illán-Cabeza, NA; Jiménez-Pulido, SB; Martínez-Martos, JM; Moreno-Carretero, MN; Peña-Ruiz, T; Ramírez-Expósito, MJ | 1 |
| Ho, SL; Leung, CH; Li, HW; Lu, L; Ma, DL; Wang, M; Zhong, HJ | 1 |
2 other study(ies) available for iridium and Neuroblastoma
| Article | Year |
|---|---|
Structural and theoretical studies on rhodium and iridium complexes with 5-nitrosopyrimidines. Effects on the proteolytic regulatory enzymes of the renin-angiotensin system in human tumoral brain cells.
Topics: Antineoplastic Agents; Autocrine Communication; Brain Neoplasms; Cell Line, Tumor; Humans; Iridium; Models, Chemical; Molecular Structure; Neuroblastoma; Nitroso Compounds; Peptide Hydrolases; Protease Inhibitors; Pyrimidines; Renin-Angiotensin System; Rhodium | 2015 |
Inhibition of Beta-Amyloid Fibrillation by Luminescent Iridium(III) Complex Probes.
Topics: Amyloid beta-Peptides; Animals; Cell Line, Tumor; Cell Survival; Humans; Iridium; Luminescent Agents; Mice; Molecular Structure; Neuroblastoma; Neurons; Protein Aggregates; Protein Aggregation, Pathological | 2015 |